how common are side effects of semaglutide Week by Week: Pharmacist's Timeline Semaglutide Side Effects: Complete Guide

Secondary analyses of these studies suggested that weight loss might be the main driver of GLP-1RA efficacy in MASH, supported by the lack of expression of GLP-1 receptors in the human liver 93

10.1007/s00011-025-01994-w 114 IranpourS.BahramiA

This may require a 3 mL syringe rather than a standard 1 mL insulin syringe

These adaptations persist for years after weight loss and actively work to restore previous weight

Sublingual tirzepatide, which dissolves under the tongue, and oral tirzepatide formulations are emerging as alternatives to traditional injections

Mild bruising is a normal and temporary response to subcutaneous injection that does not require stopping medication